Joseph Gathe, MD
Basic profilePhysician, private practice specializing in infectious diseases · Infectious Disease
Joseph Gathe is Physician, private practice specializing in infectious diseases. OpenAlex indexes 107 publications with 5,652 citations (h-index 35); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Updated 18 Oct 2026
Joseph Gathe, M.D., is Physician, private practice specializing in infectious diseases at Gathe Infectious Disease (private practice). The public record shows 107 publications with 5,652 citations (h-index 35), centered on HIV, HIV Infections, COVID-19. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 42 companies.
- Top research focus: HIV
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 42 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Principal or Co-Investigator
clinical research protocols focused on HIV care
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →defendernetwork.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4900 Fannin St
Houston, TX 77004-5706
Telephone
713-526-9821Registry record last updated 16 Dec 2008 · collected 28 Jul 2026.
Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19
Sponsor: Hope Biosciences Research Foundation
- A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
Sponsor: Therapeutic Concepts
Industry payments
Updated 18 Oct 2026
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year2025128 payments$103,837openpaymentsdata.cms.gov ↗
- EMD Serono, Inc.Program year202537 payments$39,932openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202510 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
46.5%Protease Inhibitor17.2%Prezcobix38%Symtuza26%Ritonavir15%Darunavir9%Lopinavir-Ritonavir4%Atazanavir Sulfate4%Evotaz2%Prezista1%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor7.1%Descovy38%Triumeq31%Emtricitabine-Tenofovir Disop19%Abacavir-Lamivudine8%Emtricitabine2%Zidovudine2%Part D<11 patients+ 23 more classes in this area
Cardiovascular
14.7%Angiotensin receptor blocker (ARB)3%Losartan-Hydrochlorothiazide66%Losartan Potassium29%Olmesartan Medoxomil5%Part D<11 patientsCalcium channel blocker2.9%Amlodipine Besylate96%Nifedipine Er5%Part D<11 patients+ 11 more classes in this area
Nervous system
11.6%SSRI2.3%Trazodone Hcl42%Escitalopram Oxalate23%Sertraline Hcl17%Citalopram Hbr12%Paroxetine Hcl6%Part D<11 patientsGabapentinoids1.6%Gabapentin61%Pregabalin39%Part D≥22 patients+ 15 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/joseph-gathe-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →defendernetwork.com ↗
- Diploma
American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →npin.cdc.gov ↗ - Fellow
American College of Physicians (F.A.C.P.)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →npin.cdc.gov ↗ - Fellow
Infectious Diseases Society of America (F.I.D.S.A.)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →npin.cdc.gov ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →defendernetwork.com ↗
- Fellowship training
Infectious Diseases, Methodist Hospital Houston
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →defendernetwork.com ↗
Media & interviews
press, podcasts and appearances- Segment on COVID-19 and youth
Defender Network
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →defendernetwork.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”